CreditReports.dk
HomeScreen companies

Reshape ApS Financials, key figures and credit report

CVR number: 40056173 Established 2018 Industry: 72 Scientific research and development
Company contact details
Østbanegade 55, 2100 København Ø contact@reshapebiotech.com
Gross profit 5 310.6 kDKK FY 2025 -19.6% vs 2024
EBIT -42 324.6 kDKK FY 2025 -19.5% vs 2024
Net debt -27 164.8 kDKK FY 2025 -1,482.6% vs 2024
Quick ratio 3.2 FY 2025 +1.9 vs 2024

Income statement (kDKK)

2021
2022
2023
2024
2025
Fiscal period length1212121212
Net sales
Gross profit942.951 968.771 728.936 603.215 310.62
Employee benefit expenses-3 271.45-7 040.03-13 759.16-38 850.93-41 747.21
Total depreciation- 393.99-3 170.72-5 887.98
EBIT-2 328.50-5 071.26-12 424.23-35 418.45-42 324.58
Other financial income1.2435.56263.58115.3484.70
Other financial expenses-29.61- 446.78-61.37- 254.75- 403.63
Pre-tax profit-2 356.86-5 482.48-12 222.02-35 557.86-42 643.51
Income taxes707.66843.93
Net earnings-1 649.21-4 638.55-12 222.02-35 557.86-42 643.51

Assets (kDKK)

2021
2022
2023
2024
2025
Development expenditure3 510.457 346.5014 020.6930 756.7142 447.47
Intangible assets total3 510.457 346.5014 020.6930 756.7142 447.47
Machinery and equipment53.3360.8419.01
Tangible assets total53.3360.8419.01
Investments total339.601 247.901 275.152 211.152 211.15
Long term receivables total
Finished products/goods1 590.933 798.84
Inventories total1 590.933 798.84
Current trade debtors268.06282.022 749.741 350.865 492.43
Current amounts owed by group member comp.5 006.705 602.67
Prepayments and accrued income159.52621.81642.19
Current other receivables68.21342.27661.31397.97397.98
Current deferred tax assets514.34843.931.001.60
Short term receivables total850.611 468.223 571.577 377.3412 136.87
Cash and bank deposits1 439.1718 157.889 711.121 716.4627 164.76
Cash and cash equivalents1 439.1718 157.889 711.121 716.4627 164.76
Balance sheet total (assets)6 139.8328 220.5028 631.8743 713.4387 778.10

Equity and liabilities (kDKK)

2021
2022
2023
2024
2025
Share capital540.62540.62540.62540.62540.62
Share premium account2 491.982 491.982 491.982 491.98
Other reserves2 738.155 730.2710 936.1423 990.2333 109.02
Retained earnings1 412.4722 770.1723 311.4145 098.0184 508.98
Profit of the financial year-1 649.21-4 638.55-12 222.02-35 557.86-42 643.51
Shareholders equity total5 534.0226 894.4925 058.1336 562.9975 515.12
Non-current liabilities total
Current trade creditors155.8088.249.711 530.68417.91
Other non-interest bearing current liabilities325.66490.29524.85348.39611.52
Accruals and deferred income124.35747.483 039.175 271.3811 233.55
Current liabilities total605.811 326.013 573.737 150.4512 262.98
Balance sheet total (liabilities)6 139.8328 220.5028 631.8743 713.4387 778.10
Page generated